• Publications
  • Influence
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
PURPOSE To update the American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guideline recommendations for human epidermal growth factor receptor 2 (HER2) testing inExpand
  • 2,749
  • 175
  • PDF
Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
BACKGROUND We tested the hypothesis that the level of circulating tumor cells can predict survival in metastatic breast cancer. METHODS In a prospective, multicenter study, we tested 177 patientsExpand
  • 3,576
  • 150
  • PDF
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
PURPOSE To develop a guideline to improve the accuracy of human epidermal growth factor receptor 2 (HER2) testing in invasive breast cancer and its utility as a predictive marker. METHODS TheExpand
  • 3,312
  • 145
  • PDF
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
PURPOSE To develop a guideline to improve the accuracy of human epidermal growth factor receptor 2(HER2) testing in invasive breast cancer and its utility as a predictive marker. METHODS TheExpand
  • 1,658
  • 121
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
The 13th St Gallen International Breast Cancer Conference (2013) Expert Panel reviewed and endorsed substantial new evidence on aspects of the local and regional therapies for early breast cancer,Expand
  • 2,114
  • 97
  • PDF
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
PURPOSE To develop a guideline to improve the accuracy of immunohistochemical (IHC) estrogen receptor (ER) and progesterone receptor (PgR) testing in breast cancer and the utility of these receptorsExpand
  • 2,651
  • 70
  • PDF
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
Uncontrolled proliferation is a hallmark of cancer. In breast cancer, immunohistochemical assessment of the proportion of cells staining for the nuclear antigen Ki67 has become the most widely usedExpand
  • 1,145
  • 58
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
PURPOSE To update the recommendations for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of gastrointestinal cancers. METHODS For the 2006 update, an updateExpand
  • 1,257
  • 55
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
BACKGROUND The efficacy of tamoxifen therapy for the treatment of breast cancer varies widely among individuals. Plasma concentrations of the active tamoxifen metabolite endoxifen are associated withExpand
  • 866
  • 48
Revision of the American Joint Committee on Cancer staging system for breast cancer.
PURPOSE To revise the American Joint Committee on Cancer staging system for breast carcinoma. MATERIALS AND METHODS A Breast Task Force submitted recommended changes and additions to the existingExpand
  • 1,170
  • 46
...
1
2
3
4
5
...